New Mexico Administrative Code
Title 8 - SOCIAL SERVICES
Chapter 325 - SPECIALTY SERVICES
Part 12 - MEDICATION ASSISTED TREATMENT SERVICES IN CORRECTIONAL SETTINGS
Section 8.325.12.7 - DEFINITIONS

A. Certified peer support worker (CPSW): Peer support workers who have successfully completed training with the behavioral health service division's office of peer recovery and engagement (OPRE) and have obtained certification from the New Mexico credentialing board of behavioral health professionals.

B. Clinical Assessment: A process of collecting clinical information and drawing conclusions using evidence based tools and best practices to help identify and choose pertinent interventions.

C. Community-based provider: An entity that provides substance use disorder (SUD) treatment services in the community in addition to a correctional facility.

D. Correctional facility: A state prison or county detention facility, whether operated by a government or private contractor, that is used for confinement of adult persons.

E. County detention facilities: Detention centers operated by local governments used for the confinement of adult persons.

F. Discharge planning: The process of determining a participant's continued need for treatment services and may include development of a plan to address ongoing post-treatment needs, referral into another level of care or linkage of the individual to other support services.

G. Evidence-based: Best practices based on current scientific evidence.

H. Healthcare practitioner: A person licensed by a professional licensing board or authorized to provide health care in NM and may include physicians, physician assistants, nurse practitioners or clinician pharmacists.

I. Medication for opioid use disorder (MOUD): An approach to clinical treatment that uses federal food and drug administration (FDA) approved medications for persons diagnosed with opioid use disorder (OUD).

J. Medication-assisted treatment (MAT): The use of FDA-approved medications for the treatment of SUD.

K. Naloxone: An opioid antagonist used for the complete or partial reversal of an opioid overdose.

L. Narcotic treatment program (NTP): The drug enforcement agency's term for opioid treatment program (OTP).

M. New Mexico corrections department (NMCD): The state agency overseeing NM prison facilities whether operated by state government or a private contractor.

N. Opioid use disorder (OUD): A pattern of opioid use leading to clinically significant impairment or distress, as manifested by symptoms identified in the most recent publication of the diagnostic and statistical manual of mental disorders of the American psychiatric association or its successor.

O. Opioid treatment program (OTP): A clinic that has been certified and DEA-approved, under both federal ( 42 CFR Section 8) and state (7.32.8.1 NMAC and 8.321.2.30 NMAC) regulations to provide medication for OUD treatment services with methadone.

P. Peer support workers (PSW): Individuals who have been successful in their own recovery from SUD who help other individuals in their recovery process though shared understanding, respect, and mutual empowerment, reducing the likelihood of relapse.

Q. Program participant: A person who is incarcerated and diagnosed with SUD for whom medication is clinically indicated and who elects to participate in such treatment.

R. Reentry services: Resources offered that help individuals prepare for return to their communities after incarceration. Reentry services aim to reduce recidivism and improve public safety by supporting individuals toward independent living skills. Services may include psychological and financial counseling, education, skill development, employment, housing, transportation and various types of supportive services.

S. Screening: The use of an evidence-based tool and process to identify an individual's characteristics of substance use or dependency through established criteria.

T. Substance use disorder (SUD): A pattern of use of substances leading to clinical or functional impairment, in accordance with the definition in the diagnostic and statistical manual of mental disorders (DSM-5) of the American psychiatric association, or any subsequent editions.

U. Substance use disorder treatment: Treatment services provided by specifically trained, certified or licensed professionals. SUD treatment programs can include inpatient treatment, residential programs, partial hospitalization or day treatment, outpatient and intensive outpatient programs, opioid treatment programs, and primary care-based SUD treatment services.

V. Tapering guidelines: Guidance for the clinical process by which medications are safely reduced or discontinued.

W. Telemedicine: The delivery of health care services through interactive audio, video, or other electronic media used for diagnosis, consultation, or treatment.

X. Transitional services: Resources offered to provide a continuum of support to help ensure individuals engaged in SUD treatment services have seamless access to medication, treatment and other services as needed. For this rule, transitional services also applies to program participants moving between treatment programs within facilities.

Y. Withdrawal management: The medical and psychological care of patients who are experiencing withdrawal symptoms as a result of ceasing or reducing use of a substance.